Assembly Biosciences Inc.

NASDAQ: ASMBHealthcare / Drug Manufacturers - Major / USA
14.11-0.4000-2.76%Vol 371 6181Y Perf -60.83%
Sep 20th, 2019 16:00
BID14.14 ASK14.15
Open14.65 Previous Close14.51
Pre-Market- After-Trading14.11
 - -%  - -%
Target Price
41.25 
Analyst Rating
Strong Buy 1.40
Potencial %
192.35 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)363 
Earnings Rating
Strong Buy
Price Range Ratio 52wk %
12.68 
Earnings Date
14th Nov 2019

Today's Price Range

13.9514.81

52wk Range

10.5838.42

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Week
24.32%
1 Month
11.90%
3 Months
7.55%
6 Months
-25.74%
1 Year
-60.83%
3 Years
88.89%
5 Years
71.45%
10 Years
-

Name / TickerPriceChg.Chg.%
ASMB14.11-0.4000-2.76
AAPL217.73-3.2300-1.46
GOOG1 229.93-8.7800-0.71
MSFT139.44-1.6300-1.16
XOM72.08-0.2500-0.35
WFC48.63-0.2800-0.57
JNJ131.651.54001.18
FB189.93-0.2100-0.11
GE9.37-0.0500-0.53
JPM118.90-0.4800-0.40
Earnings HistoryEstimateReportedSurprise %
Q02 2019-1.10-0.7234.55
Q01 2019-1.07-1.051.87
Q04 2018-0.91-1.03-13.19
Q03 2018-1.02-0.8714.71
Q02 2018-0.90-1.30-44.44
Q01 2018-0.76-0.80-5.26
Q04 2017--0.16-
Q03 2017-0.88-0.7119.32
Earnings Per EndEstimateRevision %Trend
9/2019 QR-0.9714.16Positive
12/2019 QR-0.9714.16Positive
12/2019 FY-3.7912.67Positive
12/2020 FY-4.1510.75Positive
Next Report Date14th Nov 2019
Estimated EPS Next Report-0.97
Estimates Count4
EPS Growth Next 5 Years %-
Volume Overview
Volume371 618
Shares Outstanding (in ths.)25 712
Trades Count1 943
Dollar Volume5 253 905
Avg. Volume277 671
Avg. Weekly Volume371 992
Avg. Monthly Volume221 123
Avg. Quarterly Volume291 617
Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
4 (80.00 %)
4 (80.00 %)
4 (80.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (20.00 %)
1 (20.00 %)
1 (20.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.40
Strong Buy
1.40
Strong Buy
1.40

Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical stage biotechnology company. It is advancing two innovative platform programs, a new class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein.

CEO: Derek A. Small

Teplephone: +1 317 210-9311

Address: 11711 North Meridian Street, Carmel 46032, IN, USA

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

40%60%

Bearish Bullish

50%50%

Bearish Bullish

47%53%

News